The most commonly reported side effects of irbesartan: include fatigue, nausea, and diarrhoea, based on 5,163 FDA adverse event reports from 2004 to 2025. 4.6% of reports found the drug to be ineffective.
Percentages show how often each reaction appears relative to total reports for irbesartan:.
These are voluntary reports and do not establish that irbesartan: caused these reactions.
Report severity
Seriousness is determined by the reporter, not by OpenClaim.
Other drugs that appear in adverse event reports alongside irbesartan:. Drugs flagged as a suspected cause appear in the first column. Drugs taken at the same time but not suspected appear in the second.
Also suspected
Taken alongside
Co-occurrence in adverse event reports does not establish a drug interaction. Patients often take multiple medications, and these lists reflect prescribing patterns rather than causal relationships. Consult a healthcare provider about potential drug interactions.
61.6% of irbesartan: adverse event reports involve female patients and 33.7% involve male patients. The largest age group is elderly at 50%. These figures reflect who reports side effects, not underlying risk.
Sex
Age group
Conditions and purposes for which patients were taking irbesartan: when the adverse event was reported.
Showing 15 of 66 indications
Irbesartan: is sold under the brand name Irbesartan; Hydrochlorothiazide.
An upward trend reflects increased FAERS reporting overall, not necessarily increased risk.
Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.